IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.
Rubino V, Hüppi M, Höpner S, Tortola L, Schnüriger N, Legenne H, Taylor L, Voggensperger S, Keller I, Bruggman R, Kronig MN, Bacher U, Kopf M, Ochsenbein AF, Riether C.
Rubino V, et al. Among authors: taylor l.
Cell Rep Med. 2024 Nov 8:101826. doi: 10.1016/j.xcrm.2024.101826. Online ahead of print.
Cell Rep Med. 2024.
PMID: 39536753
Free article.